Skip to main content

Together we are beating cancer

Donate now

Showing 12 out of 27 results
Cancer Research UK logo

Cancer Research UK's Drug Development Office marks the launch of its Biotherapeutics Development Unit (BDU) today with the manufacture of its first product - an antibody for treating a range of cancers. Cancer Research UK's Drug Development Office marks the launch of its Biotherapeutics Development Unit (BDU) today with the manufacture of its first product - an antibody for treating a range of cancers.

by Cancer Research UK | News | 30 July 2010

30 July 2010

Cancer Research UK logo

Three quarters of British adults support the removal of shop displays of tobacco (73 per cent) and a complete ban on cigarette vending machines (77 per cent) according to a new survey commissioned by Cancer Research UK this weekend. Three quarters of British adults support the removal of shop displays of tobacco (73 per cent) and a complete ban on cigarette vending machines (77 per cent) according to a new survey commissioned by Cancer Research UK this weekend.

by Cancer Research UK | News | 25 July 2010

25 July 2010

Cancer Research UK logo

Young people believe 'behind the counter' shop displays of cigarettes encourage smoking and are considered "cool, fun and attractive" according to new research published in Health Promotion Practice. Young people believe 'behind the counter' shop displays of cigarettes encourage smoking and are considered "cool, fun and attractive" according to new research published in Health Promotion Practice.

by Cancer Research UK | News | 23 July 2010

23 July 2010

Cancer Research UK logo

The number of women diagnosed with womb cancer is at its highest for over 30 years according to new figures published today by Cancer Research UK which show more than 7,530 people now* develop the disease each year in the UK. The number of women diagnosed with womb cancer is at its highest for over 30 years according to new figures published today by Cancer Research UK which show more than 7,530 people now* develop the disease each year in the UK.

by Cancer Research UK | News | 22 July 2010

22 July 2010

Cancer Research UK logo

Children given a hormone growth factor alongside chemotherapy for the aggressive cancer neuroblastoma are less likely to suffer a potentially deadly side-effect, according to a major international study published today (Tuesday) in the Journal of Clinical Oncology. Children given a hormone growth factor alongside chemotherapy for the aggressive cancer neuroblastoma are less likely to suffer a potentially deadly side-effect, according to a major international study published today (Tuesday) in the Journal of Clinical Oncology.

by Cancer Research UK | News | 20 July 2010

20 July 2010